Literature DB >> 2375596

Molecular characterization of transforming growth factor type beta 3.

P ten Dijke1, K K Iwata, M Thorikay, J Schwedes, A Stewart, C Pieler.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2375596     DOI: 10.1111/j.1749-6632.1990.tb16097.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Increased ΤGF-β3 in primary biliary cirrhosis: an abnormality related to pathogenesis?

Authors:  Argyro Voumvouraki; Mairi Koulentaki; Maria Tzardi; Ourania Sfakianaki; Penelope Manousou; George Notas; Elias Kouroumalis
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cells.

Authors:  P ten Dijke; K K Iwata; C Goddard; C Pieler; E Canalis; T L McCarthy; M Centrella
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

3.  Biochemical properties of amphibian bone morphogenetic protein-4 expressed in CHO cells.

Authors:  A Suzuki; S Nishimatsu; A Shoda; K Takebayashi; K Murakami; N Ueno
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

4.  Biological Significance of Local TGF-β Activation in Liver Diseases.

Authors:  Hiromitsu Hayashi; Takao Sakai
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

5.  Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts.

Authors:  M S Fahey; I C Paterson; A Stone; A J Collier; Y L Heung; M Davies; V Patel; E K Parkinson; S S Prime
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

6.  The induction of endochondral bone formation by transforming growth factor-beta(3): experimental studies in the non-human primate Papio ursinus.

Authors:  Ugo Ripamonti; L Nathaniel Ramoshebi; June Teare; Louise Renton; Carlo Ferretti
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.